Selected article for: "acetylsalicylic acid and acute infection"

Author: Laine, Outi; Joutsi-Korhonen, Lotta; Lassila, Riitta; Huhtala, Heini; Vaheri, Antti; Mäkelä, Satu; Mustonen, Jukka
Title: Elevated thrombopoietin and platelet indices confirm active thrombopoiesis but fail to predict clinical severity of puumala hantavirus infection
  • Document date: 2016_12_30
  • ID: jhcc6eex_5
    Snippet: The study group consisted of 33 prospectively collected consecutive adult patients (22 males), median age 45 years (range 21-67 years). Twenty-nine of the patients also participated in a previous study determining platelet indices and functions during acute PUUV infection. [10] Concomitant diseases included arterial hypertension (n = 5), diabetes mellitus (n = 3), hypercholesterolemia (n = 2), coronary heart disease (n = 2), sleep apnea (n = 2), .....
    Document: The study group consisted of 33 prospectively collected consecutive adult patients (22 males), median age 45 years (range 21-67 years). Twenty-nine of the patients also participated in a previous study determining platelet indices and functions during acute PUUV infection. [10] Concomitant diseases included arterial hypertension (n = 5), diabetes mellitus (n = 3), hypercholesterolemia (n = 2), coronary heart disease (n = 2), sleep apnea (n = 2), and celiac disease (n = 2). One patient had chronic obstructive pulmonary disease and 1 patient had undergone splenectomy because of hereditary spherocytosis. No patient was under immunosuppression or anticoagulation. Two patients received anti-platelet therapy (acetylsalicylic acid, 100 mg daily).

    Search related documents:
    Co phrase search for related documents
    • adult patient and arterial hypertension: 1
    • adult patient and heart disease: 1, 2, 3
    • adult patient and median age: 1, 2, 3
    • adult patient and obstructive pulmonary disease: 1
    • adult patient and previous study: 1
    • adult patient and pulmonary disease: 1, 2, 3, 4
    • adult patient and study group: 1, 2
    • anti platelet therapy and heart disease: 1
    • anti platelet therapy and median age: 1
    • anti platelet therapy and obstructive pulmonary disease: 1
    • anti platelet therapy and pulmonary disease: 1
    • anticoagulation immunosuppression and heart disease: 1
    • anticoagulation immunosuppression and median age: 1, 2
    • arterial hypertension and concomitant disease: 1, 2, 3
    • arterial hypertension and heart disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • arterial hypertension and median age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • arterial hypertension and obstructive pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • arterial hypertension and previous study: 1
    • arterial hypertension and pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25